Showing results (1841-1850 of 2,335) with videos related to

Sort By:
Pageof 234
Circulation|April 18, 2024
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart AssociationRichard K Cheng, Michelle M Kittleson, Craig J Beavers, et al.
Thorax|August 31, 2004
Is endosonography guided fine needle aspiration (EUS-FNA) for sarcoidosis as good as we think?S M Wildi, M A Judson, M Fraig, et al.
Respiratory Medicine and Research|July 31, 2024
Sarcoidosis Diagnostic Score (SDS) system: Impact of race, sex, organ involvement and duration of symptoms prior to diagnosisYing Zhou, Florence Jeny, Violetta Vucinic, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717)A H Calvert, D R Newell, A L Jackman, et al.
Alcoholism, Clinical and Experimental Research|November 26, 2014
Adolescent alcohol exposure alters GABAA receptor subunit expression in adult hippocampusSamuel W Centanni, Tara Teppen, Mary-Louise Risher, et al.
Journal of Cheminformatics|November 30, 2017
The CompTox Chemistry Dashboard: a community data resource for environmental chemistryAntony J Williams, Christopher M Grulke, Jeff Edwards, et al.
Advances in Experimental Medicine and Biology|April 28, 2017
Immune Response Against Salmonella Enteritidis Is Unsettled by HIV InfectionMaira Costa Cacemiro, Milena Sobral Espíndola, Leonardo Judson Galvão-Lima, et al.
Neurosurgical Review|October 16, 2025
External lumbar drain for fistula leakage in posterior fossa and spinal surgery: a systematic review with meta-analysisLuciano Falcão, João Pedro Fernandes Gonçalves, Maianna Sancho do Lago, et al.
Lancet (London, England)|November 14, 2001
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyA T van Oosterom, I Judson, J Verweij, et al.
British Journal of Cancer|October 14, 2005
A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end pointsA O'Donnell, A Padhani, C Hayes, et al.
Pageof 234